Meeting
2019 ASCO Annual Meeting
Active surveillance in metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer information system (CKCis).
Authors
Igal Kushnir
Ottawa Hospital Cancer Centre, Ottawa, ON, Canada
Igal Kushnir , Naveen S. Basappa , Sunita Ghosh , Aly-Khan A. Lalani , Denis Soulieres , Georg A. Bjarnason , Lori Wood , David Dawe , Christian K. Kollmannsberger , Daniel Yick Chin Heng , Anil Kapoor , Aaron Richard Hansen , Frederic Pouliot , M. Neil Reaume
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 4516)
DOI
10.1200/JCO.2019.37.15_suppl.4516
Abstract #
4516
Poster Bd #
342
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Active surveillance in metastatic renal cell carcinoma: A single-center cohort.
First Author: William Schwartzman
Poster
2018 Genitourinary Cancers Symposium
Improved survival rates in kidney cancer patients with brain metastases treated with modern multidisciplinary approaches.
First Author: I. Alex Bowman
Poster
2024 ASCO Genitourinary Cancers Symposium
Efficacy of perioperative pembrolizumab treatment in patients with resectable metastases from kidney cancer: The PE-PE study.
First Author: Roberto Iacovelli
Poster
2023 ASCO Genitourinary Cancers Symposium
Effects of baseline C-reactive protein on prognosis in patients with metastatic non-clear cell renal cell carcinoma treated with systemic therapy.
First Author: Ryuichi Mizuno